America's medical device recall system is under serious scrutiny. Experts say the FDA's process for pulling dangerous devices from the market is plagued by undercounting of adverse events, poor device tracking, chronic staffing shortages, and a heavy reliance on manufacturers to self-report problems. The 2021 Philips CPAP recall — linked to 561 deaths and approximately 116,000 adverse events — stands as a sobering example of what's at stake.

The cracks run deep. The FDA missed its 90-day recall completion deadline in nearly 75% of cases between 2020 and 2024, with the average taking 263 days. Class I recalls (the most serious category) have risen for five consecutive years, and real-world adverse event data in the FDA's MAUDE database is routinely overlooked in recall decisions.

By the Numbers

• 32M+ Americans will have a medical device implanted in their lifetime
• ~1,100 total recalls issued in 2025; 145 were Class I (most serious)
• 75% of recalls missed the FDA's 90-day completion deadline
• 263 days — average time to complete a recall (2020–2024)
• Only 17% of physicians report a moderate or better understanding of the FDA's device approval process

Why it matters: Clinicians aren't just bystanders — they carry legal liability if they fail to notify patients of recalls or obtain proper informed consent. With a proposed Medical Device Recall Improvement Act stalled in Congress, advocates are calling for a more transparent, patient-centered system before the next preventable tragedy strikes.